Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$0.22 - $0.46 $169 - $354
-771 Reduced 33.35%
1,541 $0
Q1 2023

Apr 27, 2023

BUY
$0.31 - $0.77 $716 - $1,780
2,312 New
2,312 $1,000
Q3 2022

Nov 04, 2022

SELL
$1.62 - $2.73 $11 - $19
-7 Reduced 10.14%
62 $0
Q2 2022

Aug 03, 2022

SELL
$1.41 - $2.77 $4,830 - $9,490
-3,426 Reduced 98.03%
69 $0
Q1 2022

May 02, 2022

BUY
$1.58 - $2.82 $5,522 - $9,855
3,495 New
3,495 $8,000

Others Institutions Holding AXLA

About Axcella Health Inc.


  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.